These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Metabolic and blood pressure monitoring in diabetic renal failure. Berglund J; Lins LE; Lins PE Acta Med Scand; 1985; 218(4):401-8. PubMed ID: 4083082 [TBL] [Abstract][Full Text] [Related]
9. The usefulness of micro- and macrochromatographic determinations of glycohemoglobin in diabetic patients with nephropathy. Saloranta C; Groop L; Ylinen K; Teramo K; Tolppanen EM; Tallgren LG Clin Nephrol; 1986 Apr; 25(4):186-92. PubMed ID: 3516481 [TBL] [Abstract][Full Text] [Related]
10. Glycosylated hemoglobin in patients treated by chronic dialysis. Hirszel P; Galen MA; Happe T; Lasrich M Int Urol Nephrol; 1981; 13(2):185-91. PubMed ID: 7327894 [TBL] [Abstract][Full Text] [Related]
11. Parameters of altered plasma glucose levels during short intervals in diabetic patients. Inoue W; Tomino Y; Miura M; Yagame M; Watanabe S; Tamura S; Kaneshige H; Nomoto Y; Sakai H Tokai J Exp Clin Med; 1986 Mar; 11(1):67-70. PubMed ID: 3810694 [TBL] [Abstract][Full Text] [Related]
12. Detection of urinary MCP-1 in patients with diabetic nephropathy. Saitoh A; Sekizuka K; Hayashi T; Kaneko S; Suzuki Y; Tomino Y Nephron; 1998 Sep; 80(1):99. PubMed ID: 9730720 [No Abstract] [Full Text] [Related]
13. Glycemic control in patients with diabetes and nephropathy. Freedman BI; Tuttle AB JAAPA; 2012 Nov; 25(11):30. PubMed ID: 23620921 [No Abstract] [Full Text] [Related]
14. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). Chujo K; Shima K; Tada H; Oohashi T; Minakuchi J; Kawashima S J Med Invest; 2006 Aug; 53(3-4):223-8. PubMed ID: 16953058 [TBL] [Abstract][Full Text] [Related]
15. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis. Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356 [TBL] [Abstract][Full Text] [Related]
16. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease. Crook ED; Patel S Ethn Dis; 2006; 16(4):865-71. PubMed ID: 17061739 [TBL] [Abstract][Full Text] [Related]
17. [The value of fructosamine in hemodialysis patients]. Küenburg E; Brunnbauer M; Watzinger U; Winter F; Müller MM; Graf H; Prager R Wien Klin Wochenschr Suppl; 1990; 180():11-3; discussion 32-3. PubMed ID: 2321384 [TBL] [Abstract][Full Text] [Related]
18. [Determination of the metabolic condition in diabetics with renal insufficiency by means of the fructosamine test]. Wagner R; Löwenstein I; Gieshoff B; Graben N; Olbricht T; Windeck R; Benker G; Reinwein D Dtsch Med Wochenschr; 1987 Jan; 112(5):175-7. PubMed ID: 3803236 [TBL] [Abstract][Full Text] [Related]
19. Origin of glycosylated hemoglobin A1 in chronic renal failure. De Marchi S; Cecchin E; Camurri C; Quaia P; Raimondi A; Donadon W; Lippi U; Tesio F Int J Artif Organs; 1983 Mar; 6(2):77-82. PubMed ID: 6840896 [TBL] [Abstract][Full Text] [Related]
20. Glycosylated hemoglobin in childhood renal disease and transplantation. O'Regan S; Prosmanne J; Letarte J; Bard H Int J Pediatr Nephrol; 1982 Mar; 3(1):17-20. PubMed ID: 7049978 [No Abstract] [Full Text] [Related] [Next] [New Search]